RE

Population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: A

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1254
Number of pages1
JournalJournal of the National Cancer Institute
Volume105
Issue number16
DOIs
StatePublished - Aug 21 2013
Externally publishedYes

Fingerprint

Uterine Cervical Dysplasia
Papillomavirus Vaccines
Condylomata Acuminata
Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Statistical Models
Uterine Cervical Neoplasms
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{ebd057a80c4a4db7a009fcd90b28bd70,
title = "RE: Population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: A",
author = "Castle, {Philip E.}",
year = "2013",
month = "8",
day = "21",
doi = "10.1093/jnci/djt187",
language = "English (US)",
volume = "105",
pages = "1254",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "16",

}

TY - JOUR

T1 - RE

T2 - Population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: A

AU - Castle, Philip E.

PY - 2013/8/21

Y1 - 2013/8/21

UR - http://www.scopus.com/inward/record.url?scp=84883152068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883152068&partnerID=8YFLogxK

U2 - 10.1093/jnci/djt187

DO - 10.1093/jnci/djt187

M3 - Letter

VL - 105

SP - 1254

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 16

ER -